Acute sensitivity of the oral mucosa to oncogenic K-ras

Journal of Pathology

Volumn 224, Issue 1, 2011, Pages 22-32

  Van Der Weyden, Louise ^a   Alcolea, Maria P ^b   Jones, Philip H ^b   Rust, Alistair G ^a   Arends, Mark J ^c   Adams, David J ^a  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b HUTCHISON MRC RESEARCH CENTRE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

carcinoma; cyclin D1.; hyperplasia; K ras; oral mucosa; pAKT; pERK

Indexed keywords

CRE RECOMBINASE; CYCLIN D1; CYTOKERATIN 13; CYTOKERATIN 6; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; RAS PROTEIN; TAMOXIFEN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE ACTIVATION; GENE AMPLIFICATION; GENE EXPRESSION; HAIR FOLLICLE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MOUSE; MOUTH MUCOSA; MOUTH TUMOR; NONHUMAN; ONCOGENE K RAS; PAPILLOMA; PRIORITY JOURNAL; SEBACEOUS GLAND; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

EID: 79953779662     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2853     Document Type: Article

References (41)

1. Bos JL,. ras oncogenes in human cancer. A review. Cancer Res 1989; 49: 4682-4689. (Pubitemid 19213607)
2. Young A, Lyons J, Miller AL, et al., Ras signaling and therapies. Adv Cancer Res 2009; 102: 1-17.
3. Adjei AA,. Blocking oncogenic Ras signaling for cancer therapy. J Natl Cancer Inst 2001; 93: 1062-1074. (Pubitemid 32717538)
4. Das N, Majumder J, DasGupta UB,. Ras gene mutations in oral cancer in eastern India. Oral Oncol 2000; 36: 76-78.
5. Brookman KC, Schönleben F, Qiu W, et al., Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 2010; 110: 632-637.
6. Shin KH, Bae SD, Hong HS, et al., miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras. Biochem Biophys Res Commun 2010; Dec 14 [Epub ahead of print]. PMID: 21167132.
7. Fisher GH, Wellen SL, Klimstra D, et al., Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumour suppressor genes. Genes Dev 2001; 15: 3249-3262. (Pubitemid 34008191)
8. Jackson EL, Willis N, Mercer K, et al., Analysis of lung tumour initiation and progression using conditional expression of oncogenic K-ras. Genes Dev 2001; 15: 3243-3248. (Pubitemid 34008190)
9. Johnson L, Mercer K, Greenbaum D, et al., Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 2001; 410: 1111-1116. (Pubitemid 32391044)
10. Meuwissen R, Linn SC, van der Valk M, et al., Mouse model for lung tumourigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene. Oncogene 2001; 20: 6551-6558. (Pubitemid 32980281)
11. Guerra C, Mijimolle N, Dhawahir A, et al., Tumour induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 2003; 4: 111-120. (Pubitemid 37040827)
12. Luo F, Brooks DG, Ye H, et al., Conditional expression of mutated K-ras accelerates intestinal tumourigenesis in Msh2-deficient mice. Oncogene 2007; 26: 4415-4427. (Pubitemid 47014468)
13. Luo F, Hamoudi R, Brooks DG, et al., Stem cell gene expression changes induced specifically by mutated K-ras. Gene Expr 2007; 14: 101-115. (Pubitemid 351211366)
14. Min/+ mice more in the large than small intestines, with synergistic effects between K-ras and Wnt pathway. Int J Exp Pathol 2009; 90: 558-574.
15. Caulin C, Nguyen T, Longley MA, et al., Inducible activation of oncogenic K-ras results in tumour formation in the oral cavity. Cancer Res 2004; 64: 5054-5058. (Pubitemid 39006517)
16. Tuveson DA, Shaw AT, Willis NA, et al., Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 2004; 5: 375-387. (Pubitemid 38482073)
17. Braun BS, Tuveson DA, Kong N, et al., Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder. Proc Natl Acad Sci U S A 2004; 101: 597-602. (Pubitemid 38084682)
18. Chan IT, Kutok JL, Williams IR, et al., Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease. J Clin Invest 2004; 113: 528-538. (Pubitemid 38542502)
19. Izeradjene K, Combs C, Best M, et al., Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell 2007; 11: 229-243. (Pubitemid 46349845)
20. Vincent DF, Yan KP, Treilleux I, et al., Inactivation of TIF1gamma cooperates with Kras to induce cystic tumours of the pancreas. PLoS Genet 2009; 5: e1000575.
21. Hameyer D, Loonstra A, Eshkind L, et al., Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues. Physiol Genomics 2007; 31: 32-41. (Pubitemid 47443846)
22. Soriano P,. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nature Genet 1999; 21: 70-71. (Pubitemid 29036285)
23. Braun KM, Niemann C, Jensen UB, et al., Manipulation of stem cell proliferation and lineage commitment: visualisation of label-retaining cells in wholemounts of mouse epidermis. Development 2003; 130: 5241-5255. (Pubitemid 37369682)
24. Vojtek AB, Der CJ,. Increasing complexity of the Ras signaling pathway. J Biol Chem 1998; 273: 19925-19928. (Pubitemid 28377538)
25. Kumamoto H, Ooya K,. Immunohistochemical detection of phosphorylated Akt, PI3K, and PTEN in ameloblastic tumours. Oral Dis 2007; 13: 461-467. (Pubitemid 47247002)
26. Marques YM, de Lima Mde D, de Melo Alves Sde M Jr, et al., Mdm2, p53, p21 and pAKT protein pathways in benign neoplasms of the salivary gland. Oral Oncology 2008; 44: 903-908.
27. van der Velden LA, Manni JJ, Ramaekers FC, et al., Expression of intermediate filament proteins in benign lesions of the oral mucosa. Eur Arch Otorhinolaryngol 1999; 256: 514-519.
28. Bloor BK, Seddon SV, Morgan PR,. Gene expression of differentiation- specific keratins in oral epithelial dysplasia and squamous cell carcinoma. Oral Oncol 2001; 37: 251-261. (Pubitemid 32245849)
29. Ohkura S, Kondoh N, Hada A, et al., Differential expression of the keratin-4, -13, -14, -17 and transglutaminase 3 genes during the development of oral squamous cell carcinoma from leukoplakia. Oral Oncol 2005; 41: 607-661.
30. Yanagawa T, Yoshida H, Yamagata K, et al., Loss of cytokeratin 13 expression in squamous cell carcinoma of the tongue is a possible sign for local recurrence. J Exp Clin Cancer Res 2007; 26: 215-220. (Pubitemid 47025285)
31. Schaaij-Visser TB, Graveland AP, Gauci S, et al., Differential proteomics identifies protein biomarkers that predict local relapse of head and neck squamous cell carcinomas. Clin Cancer Res 2009; 15: 7666-7767.
32. Freedberg IM, Tomic-Canic M, Komine M, et al., Keratins and the keratinocyte activation cycle. J Invest Dermatol 2001; 116: 633-664.
33. Hingorani SR, Petricoin EF, Maitra A, et al., Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003; 4: 437-450. (Pubitemid 38050041)
34. Pugliano FA, Piccirillo JF, Zequeira MR, et al., Clinical-severity staging system for oral cavity cancer: five-year survival rates. Otolaryngol Head Neck Surg 1999; 120: 38-45. (Pubitemid 29036317)
35. Riely GJ, Marks J, Pao W,. KRAS mutations in non-small cell lung cancer. Proc Am Thorac Soc 2009; 6: 201-205.
36. Beaupre DM, Kurzrock R,. RAS and leukemia: from basic mechanisms to gene-directed therapy. J Clin Oncol 1999; 17: 1071-1079. (Pubitemid 29109341)
37. Reuter CW, Morgan MA, Bergmann L,. Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies? Blood 2000; 96: 1655-1669. (Pubitemid 30661043)
38. Downward J,. Targeting RAS signalling pathways in cancer therapy. Nature Rev Cancer 2003; 3: 11-22. (Pubitemid 37328883)
39. Gentleman RC, Carey VJ, Bates DM, et al., Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5: R80.
40. van de Wiel MA, Kim KI, Vosse SJ, et al., CGHcall: an algorithm for calling aberrations for multiple array CGH tumor profiles. Bioinformatics 2007; 23: 892-894. (Pubitemid 47049924)
41. Venkatraman ES, Olshen AB,. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 2007; 23: 657-663. (Pubitemid 46554715)